Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Bartosz Szostak, Anna Gorący, Bartłomiej Pala, Jakub Rosik, Łukasz Ustianowski & Andrzej Pawlik. (2022) Latest models for the discovery and development of rheumatoid arthritis drugs. Expert Opinion on Drug Discovery 17:11, pages 1261-1278.
Read now
Read now
Xinmei Liao, Hui Liang, Jian Pan, Qian Zhang, Jiaqi Niu, Cuili Xue, Jian Ni & Daxiang Cui. (2021) Preparation and characterization of a fully human monoclonal antibody specific for human tumor necrosis factor alpha. Bioengineered 12:2, pages 10821-10834.
Read now
Read now
Melody Maarouf, Ashley K. Clark, Dylan E. Lee & Vivian Y. Shi. (2018) Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials. Journal of Dermatological Treatment 29:5, pages 441-449.
Read now
Read now
Michihito Sato, Kumiko Ohtsuka, Ryo Takahashi, Kuninobu Wakabayashi, Tsuyoshi Odai, Takeo Isozaki, Nobuyuki Yajima, Yusuke Miwa & Tsuyoshi Kasama. (2011) Involvement of CX3CL1/CX3CR1 axis in etanercept therapy for patients with active rheumatoid arthritis. Open Access Rheumatology: Research and Reviews 3, pages 1-7.
Read now
Read now
Kim A Papp. (2004) Etanercept in psoriasis. Expert Opinion on Pharmacotherapy 5:10, pages 2139-2146.
Read now
Read now
Allen P Anandarajah & Christopher T Ritchlin. (2003) Etanercept in psoriatic arthritis. Expert Opinion on Biological Therapy 3:1, pages 169-177.
Read now
Read now
Adrian Bot, William J Phillips & Matthias von Herrath. (2002) Antigen-based immune modulation: DNA vectors and beyond. Expert Opinion on Biological Therapy 2:8, pages 929-942.
Read now
Read now
Rafael Fernandez-Botran, Xichun Sun & Fabian A Crespo. (2002) Soluble cytokine receptors in biological therapy. Expert Opinion on Biological Therapy 2:6, pages 585-605.
Read now
Read now
Helena Linardou & Samuel Murray. (2002) Non-cancer therapeutic antibodies. Expert Opinion on Therapeutic Patents 12:3, pages 401-417.
Read now
Read now
Articles from other publishers (44)
Dhuha F.N. Bani-Wais & Ali H. Ad'hiah. (2023) A novel intergenic variant, rs2004339 A/G, of the gene encoding interleukin-40, C17orf99, is associated with risk of rheumatoid arthritis in Iraqi women. Molecular Immunology 164, pages 39-46.
Crossref
Crossref
Benjamin L. Allen, Karli Montague-Cardoso, Raffaele Simeoli, Romain A. Colas, Silvia Oggero, Bruno Vilar, Peter A. McNaughton, Jesmond Dalli, Mauro Perretti, Emanuele Sher & Marzia Malcangio. (2020) Imbalance of proresolving lipid mediators in persistent allodynia dissociated from signs of clinical arthritis. Pain 161:9, pages 2155-2166.
Crossref
Crossref
Yen-Ju Lin, Martina Anzaghe & Stefan Schülke. (2020) Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells 9:4, pages 880.
Crossref
Crossref
Huanbo Tan, Wencheng Su, Wenyu Zhang, Pengju Wang, Michael Sattler & Peijian Zou. (2019) Recent Advances in Half-life Extension Strategies for Therapeutic Peptides and Proteins. Current Pharmaceutical Design 24:41, pages 4932-4946.
Crossref
Crossref
Rahul Bodkhe, Baskar Balakrishnan & Veena Taneja. (2019) The role of microbiome in rheumatoid arthritis treatment. Therapeutic Advances in Musculoskeletal Disease 11, pages 1759720X1984463.
Crossref
Crossref
J. Rojo, A. Sousa-Herves & A. Mascaraque. 2017. Comprehensive Medicinal Chemistry III. Comprehensive Medicinal Chemistry III
577
610
.
Shayne Cox GadJoan Korth-Bradley. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Anne Chastre, Mireille Bélanger, Elizabeth Beauchesne, Bich N. Nguyen, Paul Desjardins & Roger F. Butterworth. (2012) Inflammatory Cascades Driven by Tumor Necrosis Factor-Alpha Play a Major Role in the Progression of Acute Liver Failure and Its Neurological Complications. PLoS ONE 7:11, pages e49670.
Crossref
Crossref
Andrew Erdman, James Nickas & Benton Brown. 2011. Stephens' Detection and Evaluation of Adverse Drug Reactions. Stephens' Detection and Evaluation of Adverse Drug Reactions
585
601
.
Frank Euteneuer, Markus J. Schwarz, Anika Hennings, Sabine Riemer, Theresa Stapf, Verena Selberdinger & Winfried Rief. (2011) Depression, cytokines and experimental pain: Evidence for sex-related association patterns. Journal of Affective Disorders 131:1-3, pages 143-149.
Crossref
Crossref
Masao Sato, Masao Takemura, Ryuki Shinohe & Katsuji Shimizu. (2011) Serum Cytokine Concentrations in a Patient with Rheumatoid Arthritis on Etanercept Therapy Who Subsequently Developed Pneumocystis Pneumonia: A Case Report. Case Reports in Rheumatology 2011, pages 1-4.
Crossref
Crossref
Antonio G. Tristano. (2010) Neurological adverse events associated with anti-tumor necrosis factor alpha treatment. Journal of Neurology 257:9, pages 1421-1431.
Crossref
Crossref
Amer Alshekhlee, Kevian Basiri, J. Douglas Miles, Saef A. Ahmad & Bashar Katirji. (2010) Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-α antagonists. Muscle & Nerve 41:5, pages 723-727.
Crossref
Crossref
Daniel E. Furst. (2010) The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis. Seminars in Arthritis and Rheumatism 39:5, pages 327-346.
Crossref
Crossref
E Mazzon, E Esposito, R Di Paola, C Muià, C Crisafulli, T Genovese, R Caminiti, R Meli, P Bramanti & S Cuzzocrea. (2008) Effect of tumour necrosis factor-α receptor 1 genetic deletion on carrageenan-induced acute inflammation: a comparison with etanercept. Clinical and Experimental Immunology 153:1, pages 136-149.
Crossref
Crossref
Joerg-Patrick Stübgen. (2008) Tumor necrosis factor-α antagonists and neuropathy. Muscle & Nerve 37:3, pages 281-292.
Crossref
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Christopher Bibbo. (2007) Wound Healing Complications and Infection Following Surgery for Rheumatoid Arthritis. Foot and Ankle Clinics 12:3, pages 509-524.
Crossref
Crossref
A. Claudio CuelloEdith G. McGeer & Patrick L. McGeer. 2007. Pharmacological Mechanisms in Alzheimer's Therapeutics. Pharmacological Mechanisms in Alzheimer's Therapeutics
149
166
.
Toru Nakazawa, Chifuyu Nakazawa, Akihisa Matsubara, Kousuke Noda, Toshio Hisatomi, Haicheng She, Norman Michaud, Ali Hafezi-Moghadam, Joan W. Miller & Larry I. Benowitz. (2006) Tumor Necrosis Factor-α Mediates Oligodendrocyte Death and Delayed Retinal Ganglion Cell Loss in a Mouse Model of Glaucoma. The Journal of Neuroscience 26:49, pages 12633-12641.
Crossref
Crossref
. 2006. Wiley Handbook of Current and Emerging Drug Therapies. Wiley Handbook of Current and Emerging Drug Therapies.
Sanford H Roth. (2006) Role of Apheresis in Rheumatoid Arthritis. Drugs 66:15, pages 1903-1908.
Crossref
Crossref
Mi-Jung Yeom, Han-Chang Lee, Gun-Ho Kim, Hye-Jung Lee, Insop Shim, Seung-Kyu Oh, Sung-Keel Kang & Dae-Hyun Hahm. (2006) Anti-arthritic Effects of Ephedra sinica STAPF Herb-Acupuncture: Inhibition of Lipopolysaccharide-Induced Inflammation and Adjuvant-Induced Polyarthritis. Journal of Pharmacological Sciences 100:1, pages 41-50.
Crossref
Crossref
Areej H. Mufti, Baldwin W. Toye, Robert R.J. Mckendry & Jonathan B. Angel. (2005) Mycobacterium abscessus infection after use of tumor necrosis factor α inhibitor therapy: case report and review of infectious complications associated with tumor necrosis factor α inhibitor use. Diagnostic Microbiology and Infectious Disease 53:3, pages 233-238.
Crossref
Crossref
A. Sparsa. (2005) Etanercept. Annales de Dermatologie et de Vénéréologie 132:11, pages 861-876.
Crossref
Crossref
Srinivasan Madhusudan, Sethupathi R. Muthuramalingam, Jeremy P. Braybrooke, Susan Wilner, Kulwinder Kaur, Cheng Han, Susan Hoare, Frances Balkwill & Trivadi S. Ganesan. (2005) Study of Etanercept, a Tumor Necrosis Factor-Alpha Inhibitor, in Recurrent Ovarian Cancer. Journal of Clinical Oncology 23:25, pages 5950-5959.
Crossref
Crossref
Guido Seitz, Steven W. Warmann, Andres Guglielmetti, Heike Heitmann, Peter Ruck, Martin E. Kreis & Jörg Fuchs. (2005) Protective effect of tumor necrosis factor α antibody on experimental necrotizing enterocolitis in the rat. Journal of Pediatric Surgery 40:9, pages 1440-1445.
Crossref
Crossref
A. Sabokbar, I. Itonaga, S. G. Sun, O. Kudo & N. A. Athanasou. (2005) Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening. Journal of Orthopaedic Research 23:3, pages 511-519.
Crossref
Crossref
Srinivasan Madhusudan, Martin Foster, Sethupathi R. Muthuramalingam, Jeremy P. Braybrooke, Susan Wilner, Kulwinder Kaur, Cheng Han, Susan Hoare, Frances Balkwill, Denis C. Talbot, Trivadi S. Ganesan & Adrian L. Harris. (2004) A Phase II Study of Etanercept (Enbrel), a Tumor Necrosis Factor α Inhibitor in Patients with Metastatic Breast Cancer. Clinical Cancer Research 10:19, pages 6528-6534.
Crossref
Crossref
Gary Walsh. (2004) Second-generation biopharmaceuticals. European Journal of Pharmaceutics and Biopharmaceutics 58:2, pages 185-196.
Crossref
Crossref
Christopher Bibbo & Jerry W. Goldberg. (2016) Infectious and Healing Complications after Elective Orthopaedic Foot and Ankle Surgery during Tumor Necrosis Factor-Alpha Inhibition Therapy. Foot & Ankle International 25:5, pages 331-335.
Crossref
Crossref
Xinrui Yan, Xuwen Gao & Zhiqing Zhang. (2004) Isolation and Characterization of 2′-amino-modified RNA Aptamers for Human TNFα. Genomics, Proteomics & Bioinformatics 2:1, pages 32-42.
Crossref
Crossref
Howard B. Cottam. 2001. Kirk-Othmer Encyclopedia of Chemical Technology. Kirk-Othmer Encyclopedia of Chemical Technology.
Edith G. McGeer & Patrick L. McGeer. (2003) Inflammatory processes in Alzheimer's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry 27:5, pages 741-749.
Crossref
Crossref
P. Rutgeerts, S. Van Deventer & S. Schreiber. (2003) The expanding role of biological agents in the treatment of inflammatory bowel disease - focus on selective adhesion molecule inhibition. Alimentary Pharmacology & Therapeutics 17:12, pages 1435-1450.
Crossref
Crossref
Tomoyuki Izumi, Jun Sakaguchi, Makoto Takeshita, Harumi Tawara, Ken-ichi Kato, Hitomi Dose, Tomomi Tsujino, Yoshinari Watanabe & Hideo Kato. (2003) 1H-Imidazo[4,5-c]quinoline derivatives as novel potent TNF-α suppressors: synthesis and structure–activity relationship of 1-, 2-and 4-substituted 1H-imidazo[4,5-c]quinolines or 1H-imidazo[4,5-c]pyridines. Bioorganic & Medicinal Chemistry 11:12, pages 2541-2550.
Crossref
Crossref
JC Prinz. (2003) The role of T cells in psoriasis. Journal of the European Academy of Dermatology and Venereology 17:3, pages 257-270.
Crossref
Crossref
Apostolia-Maria Tsimberidou, Tracey Waddelow, Hagop M Kantarjian, Maher Albitar & Francis J Giles. (2003) Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNFα levels during treatment. Leukemia Research 27:5, pages 375-380.
Crossref
Crossref
Darren C Phillips, Kevin J Woollard & Helen R Griffiths. (2003) The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. British Journal of Pharmacology 138:3, pages 501-511.
Crossref
Crossref
Mi-Jung Yeom, Han-Chang Lee, Gun-Ho Kim, Insop Shim, Hye-Jung Lee & Dae-Hyun Hahm. (2003) Therapeutic Effects of <i>Hominis placenta</i> Injection into an Acupuncture Point on the Inflammatory Responses in Subchondral Bone Region of Adjuvant-Induced Polyarthritic Rat. Biological & Pharmaceutical Bulletin Biological and Pharmaceutical Bulletin 26:10, pages 1472-1477.
Crossref
Crossref
A. Sabokbar, O. Kudo & N. A. Athanasou. (2006) Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. Journal of Orthopaedic Research 21:1, pages 73-80.
Crossref
Crossref
Li Li, Anuk M Das, Theodore J Torphy & Don E Griswold. (2002) What's in the Pipeline? Prospects for Monoclonal Antibodies (mAbs) as Therapies for Lung Diseases. Pulmonary Pharmacology & Therapeutics 15:5, pages 409-416.
Crossref
Crossref
Trent M. Woodruff, Anna J. Strachan, Nathan Dryburgh, Ian A. Shiels, Robert C. Reid, David P. Fairlie & Stephen M. Taylor. (2002) Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat. Arthritis & Rheumatism 46:9, pages 2476-2485.
Crossref
Crossref
Patrick L. McGeerEdith G. McGeer. (2002) Innate Immunity, Local Inflammation, and Degenerative Disease. Science of Aging Knowledge Environment 2002:29.
Crossref
Crossref